FindTrial
Sign In

Antimicrobials used against uropathogens causing Urinary Tract Infection (UTI) and also to study the drug resistance(capacity of disease causing micro-organisms to withstand exposure to drugs) and sensitivity patterns.

A clinical study of UTI caused by Multi-Drug Resistant (MDR) uropathogens in a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/12/022486
Enrollment
1500
Registered
2019-12-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: NIL: NIL

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects whose urine sample when processed showed significant growth of one or more organisms.

Exclusion criteria

Exclusion criteria: 1. Subjects whose urine sample was contaminated. 2. Subjects whose urine sample showed no growth. 3. Subjects whose urine sample showed insignificant bacteriuria.

Design outcomes

Primary

MeasureTime frame
1. MDR Uropathogens causing UTI Timepoint: 6 months—

Secondary

MeasureTime frame
1. Antimicrobial susceptibility pattern 2. Clinical course and outcomeTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Vijendra R

KIMS, Bangalore

vijendra_ramaiah@yahoo.co.in09980033334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026